Allan, Stuart M.

Interleukin-1 and neuronal injury

Allan, S. M., Tyrrell, P. J., & Rothwell, N. J. (2005) · Nature Reviews Immunology

Neuroinflammation and Neurodegeneration MechanismsTryptophan and brain disorders

Cited by 992

Vascular dysfunction—The disregarded partner of Alzheimer's disease

Sweeney, M. D., Montagne, A., Sagare, A. P., Nation, D. A., Schneider, L. S., Chui, H. C., Harrington, M. G., Pa, J., Law, M., Wang, D. J. J., et al. (2019) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchNeurological Disease Mechanisms and Treatments

Cited by 711

Impaired Adult Neurogenesis in the Dentate Gyrus of a Triple Transgenic Mouse Model of Alzheimer's Disease

Rodríguez, J. J., Jones, V. C., Tabuchi, M., Allan, S. M., Knight, E. M., LaFerla, F. M., Oddo, S., & Verkhratsky, A. (2008) · PLoS ONE

Neurogenesis and neuroplasticity mechanismsAlzheimer's disease research and treatments

Cited by 377

Proliferating resident microglia after focal cerebral ischaemia in mice

Denes, A., Vidyasagar, R., Feng, J., Narvainen, J., McColl, B. W., Kauppinen, R. A., & Allan, S. M. (2007) · Journal of Cerebral Blood Flow & Metabolism

Neuroinflammation and Neurodegeneration MechanismsNeurological Disease Mechanisms and Treatments

Cited by 342

Systemic Inflammatory Stimulus Potentiates the Acute Phase and CXC Chemokine Responses to Experimental Stroke and Exacerbates Brain Damage via Interleukin-1- and Neutrophil-Dependent Mechanisms

McColl, B. W., Rothwell, N. J., & Allan, S. M. (2007) · The Journal of Neuroscience

Neuroinflammation and Neurodegeneration MechanismsAcute Ischemic Stroke Management

Cited by 337

The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke

Cunningham, C. J., Redondo-Castro, E., & Allan, S. M. (2018) · Journal of Cerebral Blood Flow & Metabolism

Mesenchymal stem cell researchExtracellular vesicles in disease

Cited by 242

High-fat diet-induced memory impairment in triple-transgenic Alzheimer’s disease (3xTgAD) mice is independent of changes in amyloid and tau pathology.

Knight, E. M., Martins, I. V. A., Gümüsgöz, S., Allan, S. M., & Lawrence, C. B. (2014) · Neurobiology of Aging

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 232

Interleukin‐1 in the Brain: Mechanisms of Action in Acute Neurodegeneration

PATEL, H. C., BOUTIN, H., & ALLAN, S. M. (2003) · Annals of the New York Academy of Sciences

Neuroinflammation and Neurodegeneration MechanismsTryptophan and brain disorders

Cited by 139

Microglial Priming as Trained Immunity in the Brain

Haley, M. J., Brough, D., Quintin, J., & Allan, S. M. (2019) · Neuroscience

Immune responses and vaccinationsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 104

A cross-laboratory preclinical study on the effectiveness of interleukin-1 receptor antagonist in stroke

Maysami, S., Wong, R., Pradillo, J. M., Denes, A., Dhungana, H., Malm, T., Koistinaho, J., Orset, C., Rahman, M., Rubio, M., et al. (2016) · Journal of Cerebral Blood Flow & Metabolism

Neuroinflammation and Neurodegeneration MechanismsAcute Ischemic Stroke Management

Cited by 84

Enhanced susceptibility of triple transgenic Alzheimer’s disease (3xTg-AD) mice to acute infection

Montacute, R., Foley, K., Forman, R., Else, K. J., Cruickshank, S. M., & Allan, S. M. (2017) · Journal of Neuroinflammation

Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments

Cited by 43